Back to Awarded Treatment Trials
Awarded Trial: 07TGS-1049
Grant ID
07TGS-1049
Illness
Schizophrenia
Primary Drug/Intervention
L-Lysine
Primary Dosage
6 g/day
Secondary Drug Intervention
N/A
Secondary Dosage
N/A
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Completed
Investigator
Engel
Sample Size
10
Duration of Study Period for Each Subject
120 days
Outcome Measurements
CGI, BPRS, SANS
Results
This was a small open study of L-lysine as an adjunct for 10 patients with schizophrenia. Among the 8 patients who completed the study, there was a significant improvement in positive symptoms and WCST scores.
Publication
N/A
Link
N/A
PI Name
Jorgen Engel
Degree
MD
Center
N/A
Institution
Neuroscience and Physiology
Address
POB 431, Department of Pharmacology
City or Town
Goteborg
State or Province
N/A
Zip or Postal Code
SE40530
Country
Sweden
Email Address
jorgen.engel@pharm.gu.se